New radiation approach aims to shrink pancreatic tumors in just five sessions

NCT ID NCT05191940

Recruiting now Disease control Sponsor: EBG MedAustron GmbH Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a short, high-dose radiation therapy for people with locally advanced pancreatic cancer that cannot be removed by surgery. The treatment uses protons or carbon ions to deliver a precise, powerful dose in only five sessions. Researchers hope this approach will improve tumor control while reducing the number of hospital visits.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Proton or carbon ion radiation therapy
What this could lead to: If successful, this could offer a more convenient and effective radiation option for patients with inoperable pancreatic cancer, potentially improving local tumor control.
What could go wrong: This is a small, early-phase trial with only 30 participants, so results may not apply to everyone. High-dose radiation also carries risks of damage to nearby organs.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED PANCREATIC CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

malignant pancreatic neoplasm pancreatic adenocarcinoma pancreatic neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PANCREAS CANCER

Contacts and locations

Locations

EBG MedAustron GmbH
RECRUITING

Wiener Neustadt, Lower Austria, 2700, Austria

More trials for these conditions

Other studies related to the condition(s) this trial covers.